The effect of montelukast added to steroid on airway function as compared with steroid alone and placebo: a single blind, controlled study in acute asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001
Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009
For how much time and with which dose of inhaled steroids it is possible to maintain asthma control? A randomized prospective study Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007
Paracetamol increases airway resistance in stable asthmatics: A double blind, randomized, placebo controlled study Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders? Year: 2010
The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
Nasal beclomethasone plus loratadine in patients with rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007
A randomized placebo controlled trial of AZD8871 a novel dual acting bronchodilator in asthmatics. Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial) Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
High or standard initial dose of budesonide to control mild-to-moderate asthma? Source: Eur Respir J 2001; 17: 856-862 Year: 2001
A randomized placebo controlled trial of AZD8999 (LAS190792) a novel dual acting bronchodilator in asthmatics Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017
A multicenter, open-label, randomized comparison of the effects of HFA-BDP and FP on asthmatic inflammation of lower airways and health-related quality of life Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007
Steroid sparing effect and the influence on height of Montelukast therapy in the treatment of asthmatic children: a retrospective observational study Source: Eur Respir J 2001; 18: Suppl. 33, 290s Year: 2001
Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Ciclesonide significantly improves pulmonary function when compared with budesonide: a randomized 12-week study Source: Eur Respir J 2003; 22: Suppl. 45, 411s Year: 2003
Is overall asthma control being achieved? A hypothesis-generating study Source: Eur Respir J 2001; 17: 589-595 Year: 2001